J
John R. Ingram
Researcher at Cardiff University
Publications - 160
Citations - 3218
John R. Ingram is an academic researcher from Cardiff University. The author has contributed to research in topics: Hidradenitis suppurativa & Medicine. The author has an hindex of 26, co-authored 129 publications receiving 2129 citations. Previous affiliations of John R. Ingram include University Hospital of Wales & Cardiff and Vale University Health Board.
Papers
More filters
Journal ArticleDOI
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Emilie Sbidian,Anna Chaimani,Ignacio García-Doval,Giao Do,Camille Hua,C. Mazaud,Catherine Droitcourt,Carolyn Hughes,John R. Ingram,Luigi Naldi,Olivier Chosidow,L. Le Cleach +11 more
TL;DR: A network meta-analysis of randomised controlled trials of systemic and biological treatments in adults with moderate to severe plaque psoriasis or psoriatic arthritis and a ranking of these treatments according to their efficacy and safety is conducted.
Journal ArticleDOI
Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.
Christos C. Zouboulis,Thrasyvoulos Tzellos,Athanassios Kyrgidis,Gregor B.E. Jemec,F.G. Bechara,Evangelos J. Giamarellos-Bourboulis,John R. Ingram,Theodora Kanni,Ioannis Karagiannidis,Antonio Martorell,Lukasz Matusiak,Andreas Pinter,Errol P. Prens,D. Presser,Sylke Schneider-Burrus,E. von Stebut,Jacek C Szepietowski,H.H. van der Zee,Sophia Wilden,Robert Sabat +19 more
TL;DR: A validated tool for the dynamic severity assessment of hidradenitis suppurativa/acne inversa (HS) is lacking.
Journal ArticleDOI
Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa.
John R. Ingram,Sara Jenkins-Jones,Duleeka Knipe,CL Morgan,Rebecca Cannings-John,Vincent Piguet,Vincent Piguet,Vincent Piguet +7 more
TL;DR: Epidemiology data regarding hidradenitis suppurativa (HS) are conflicting and prevalence estimates vary 80‐fold, from 0·05% in a population‐based study to 4%.
Journal ArticleDOI
Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial
Hywel C Williams,Fenella Wojnarowska,Gudula Kirtschig,Gudula Kirtschig,James Mason,Thomas R. Godec,Enno Schmidt,Joanne R Chalmers,Margaret Childs,S. Walton,Karen E. Harman,A. Chapman,Diane Whitham,Andrew J. Nunn,J Adams,V Akhras,Alexander Vincent Anstey,C Barnard,H K Bell,S Blackford,Eva-B. Bröcker,A Carmichael,R.R. Coelho,Fiona Craig,K Davies,Robert Ellis,John C. English,Regine Gläser,Richard Groves,C Günthert,P J Hampton,N. Hepburn,Rainer Hügel,K. Hussain,John R. Ingram,Alison M Layton,Nick J. Levell,V Lewis,H Malhomme,A Omerod,Girish Khandubhai Patel,R Rallan,Jane Ravenscroft,H Santander,Kerstin Steinbrink,Michael Sticherling,C Thomas,M Vatve,N. van Beek,V Venning,Emma Veysey,R. Wachsmuth,Shyamal Wahie,B Walker,M Walsh,J Wee,M Westmoreland,G Wong,Adam Ferguson,Indre Verpetinske,Emilia Duarte-Williamson,Fiona Antony,Chris Bower,David Gawkrodger,Kathy Taghipour,M G S Dunnill,Alex Waters,Walter Bottomley,Andrew M Wright,Jane C. Sterling,Adzura Azam,Sam Gibbs,Thomas A. Luger,Ingrid Salvary,Chris Lovell,Andrew Ilchyshyn,Karen Gibbon,Marinella Nik,Robert Charles-Holmes,A Lloyd Lavery +79 more
TL;DR: Starting patients on doxycycline is non-inferior to standard treatment with oral prednisolone for short-term blister control in bullous pemphigoid and significantly safer in the long-term.
Journal ArticleDOI
Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project
Amit Garg,Erica Neuren,Denny Cha,Joslyn S. Kirby,John R. Ingram,Gregor B.E. Jemec,Solveig Esmann,L. Thorlacius,B. Villumsen,Véronique Del Marmol,Aude Nassif,Maïa Delage,Thrasyvoulos Tzellos,Dagfinn Moseng,Øystein Grimstad,Haley B. Naik,Robert G. Micheletti,S. Guilbault,Angie Parks Miller,Iltefat H. Hamzavi,Hessel H. van der Zee,Errol P. Prens,Naomi Kappe,Christine B. Ardon,Brian Kirby,R. Hughes,Christos C. Zouboulis,Georgios Nikolakis,Falk G. Bechara,Lukasz Matusiak,Jacek C Szepietowski,Amelia Głowaczewska,Saxon D Smith,Noah Goldfarb,Steven Daveluy,Christina Avgoustou,Evangelos J. Giamarellos-Bourboulis,Steven R. Cohen,Yssra Soliman,Elena Gonzalez Brant,Oleg E. Akilov,Christopher Sayed,Jerry Tan,Afsaneh Alavi,Michelle A. Lowes,José C. Pascual,Hassan Riad,Shani Fisher,Arnon D. Cohen,So Yeon Paek,Barry I. Resnik,Qiang Ju,Lanqi Wang,Andrew Strunk +53 more
TL;DR: HS patients have identified several critical unmet needs that will require stakeholder collaboration to meaningfully address in multidisciplinary care, treatment, research, advocacy, and philanthropy.